Cancer Survivorship and Subclinical Myocardial Damage
- PMID: 30927355
- PMCID: PMC7212406
- DOI: 10.1093/aje/kwz088
Cancer Survivorship and Subclinical Myocardial Damage
Abstract
Cancer survivors might have an excess risk of cardiovascular disease (CVD) resulting from toxicities of cancer therapies and a high burden of CVD risk factors. We sought to evaluate the association of cancer survivorship with subclinical myocardial damage, as assessed by elevated high-sensitivity cardiac troponin T (hs-cTnT) test results. We included 3,512 participants of the Atherosclerosis Risk in Communities Study who attended visit 5 (2011-2013) and were free of CVD (coronary heart disease, heart failure, or stroke). We used multivariate logistic regression to evaluate the cross-sectional associations of survivorship from any, non-sex-related, and sex-related cancers (e.g., breast, prostate) with elevated hs-cTnT (≥14 ng/L). Of 3,512 participants (mean age, 76 years; 62% women; 21% black), 19% were cancer survivors. Cancer survivors had significantly higher odds of elevated hs-cTnT (OR = 1.26, 95% CI: 1.03, 1.53). Results were similar for survivors of non-sex-related and colorectal cancers, but there was no association between survivorship from breast and prostate cancers and elevated hs-cTnT. Results were similar after additional adjustments for CVD risk factors. Survivors of some cancers might be more likely to have elevated hs-cTnT than persons without prior cancer. The excess burden of subclinical myocardial damage in this population might not be fully explained by traditional CVD risk factors.
Keywords: ARIC; biomarkers; cancer; cardiovascular disease; hs-cTnT.
© The Author(s) 2019. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
References
-
- Miller KD, Siegel RL, Lin CC, et al. . Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin. 2016;66(4):271–289. - PubMed
-
- Oeffinger KC, Mertens AC, Sklar CA, et al. . Chronic health conditions in adult survivors of childhood cancer. N Engl J Med. 2006;355(15):1572–1582. - PubMed
-
- Armenian SH, Lacchetti C, Barac A, et al. . Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2017;35(8):893–911. - PubMed
-
- de Lemos JA. Increasingly sensitive assays for cardiac troponins: a review. JAMA. 2013;309(21):2262–2269. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- K23 HL122447/HL/NHLBI NIH HHS/United States
- P30 CA006973/CA/NCI NIH HHS/United States
- R01 DK089174/DK/NIDDK NIH HHS/United States
- T32 HL007024/HL/NHLBI NIH HHS/United States
- HHSN268201700002C/HL/NHLBI NIH HHS/United States
- HHSN268201700001I/HL/NHLBI NIH HHS/United States
- HHSN268201700004C/HL/NHLBI NIH HHS/United States
- HHSN268201700003I/HL/NHLBI NIH HHS/United States
- K24 DK106414/DK/NIDDK NIH HHS/United States
- HHSN268201700004I/HL/NHLBI NIH HHS/United States
- HHSN268201700005C/HL/NHLBI NIH HHS/United States
- HHSN268201700001C/HL/NHLBI NIH HHS/United States
- HHSN268201700003C/HL/NHLBI NIH HHS/United States
- HHSN268201700002I/HL/NHLBI NIH HHS/United States
- HHSN268201700005I/HL/NHLBI NIH HHS/United States
- R01 HL146907/HL/NHLBI NIH HHS/United States
- U01 CA164975/CA/NCI NIH HHS/United States
- R01 HL134320/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
